Kewaunee Scientific Corporation (KEQU) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Kewaunee Scientific Corporation (KEQU) Consumer Business Overview

Kewaunee Scientific Corporation, founded in 1906, specializes in designing, manufacturing, and installing laboratory, healthcare, and technical furniture. Operating through Domestic and International segments, the company provides a diverse product range, including steel, wood, and laminate furniture, serving pharmaceutical, biotechnology, and healthcare markets with a P/E ratio of 12.08.

What Is the Investment Thesis for KEQU?

With a P/E ratio of 12.08 and a gross margin of 28.9%, the company demonstrates financial stability. Growth catalysts include expansion in the healthcare and biotechnology sectors, driven by increased R&D spending. The company's international segment also presents growth opportunities. Potential risks include economic downturns affecting capital spending in the laboratory and healthcare sectors, as well as competition from other furniture manufacturers. The company's beta of 0.67 suggests lower volatility compared to the broader market.

Based on FMP financials and quantitative analysis

KEQU Key Highlights

Market capitalization of $99.1M indicates a small-cap company with potential for growth.

• P/E ratio of 12.08 suggests the company may be undervalued compared to its earnings.
• Gross margin of 28.9% reflects the company's ability to manage production costs effectively.
• Profit margin of 3.9% indicates profitability, though there is room for improvement.
• Beta of 0.67 suggests lower volatility compared to the overall market, potentially making it a more stable investment.

Who Are KEQU's Competitors?

KEQU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are KEQU's Key Strengths?

Long-standing history and established reputation.

• Diverse product portfolio serving multiple industries.
• Global presence through Domestic and International segments.
• Comprehensive solutions including design and installation services.

What Are KEQU's Weaknesses?

Relatively small market capitalization.

• Lower profit margin compared to some competitors.
• Dependence on capital spending in specific sectors.
• Limited brand recognition compared to larger furniture manufacturers.

What Could Drive KEQU Stock Higher?

Increased R&D spending in the pharmaceutical and biotechnology sectors driving demand for laboratory furniture.

• Expansion of healthcare facilities and diagnostic laboratories creating opportunities for growth.
• Potential new product launches featuring innovative designs and technologies by Q4 2026.
• Strategic partnerships with key industry players to expand market reach.

What Are the Key Risks for KEQU?

Insider selling — insiders were net sellers of roughly $2.5M recently.

• Economic downturns affecting capital spending in the laboratory and healthcare sectors.
• Intense competition from other furniture manufacturers.
• Fluctuations in raw material prices impacting production costs.
• Changes in regulatory requirements affecting laboratory and healthcare industries.
• Disruptions in the supply chain due to global events.

What Are the Growth Opportunities for KEQU?

• Expansion in the Healthcare Sector: The increasing demand for advanced healthcare facilities and diagnostic laboratories presents a significant growth opportunity for Kewaunee. The healthcare sector is experiencing substantial growth, driven by an aging population and advancements in medical technology. Kewaunee can capitalize on this trend by offering specialized furniture and infrastructure solutions for hospitals, clinics, and research institutions. This market is estimated to reach $400 billion by 2028, providing a substantial runway for growth.
• Penetration of the Biotechnology Market: The biotechnology industry is experiencing rapid growth, fueled by advancements in genetic engineering and personalized medicine. This growth is driving demand for advanced laboratory facilities and equipment. Kewaunee can leverage its expertise in designing and manufacturing laboratory furniture to capture a larger share of this market. The global biotechnology market is projected to reach $1 trillion by 2027, offering significant growth potential for Kewaunee.
• Growth in International Markets: Kewaunee's international segment presents a significant growth opportunity. Emerging markets, particularly in Asia and Latin America, are experiencing rapid economic growth and increasing investments in research and development. Kewaunee can expand its presence in these markets by establishing strategic partnerships and offering customized solutions tailored to local needs. The international laboratory furniture market is expected to grow at a CAGR of 6% over the next five years.
• Product Innovation and Development: Continuous innovation in product design and functionality is crucial for maintaining a competitive edge. Kewaunee can invest in research and development to create new and improved products that meet the evolving needs of its customers. This includes developing modular and flexible furniture systems, as well as integrating advanced technologies such as automation and robotics into its products. Investing in R&D can lead to higher margins and increased market share.
• Strategic Acquisitions and Partnerships: Kewaunee can pursue strategic acquisitions and partnerships to expand its product portfolio and geographic reach. Acquiring complementary businesses can provide access to new technologies, markets, and customers. Forming partnerships with other companies can also enhance Kewaunee's capabilities and competitiveness. For example, partnering with a company specializing in laboratory automation could enhance Kewaunee's product offerings and attract new customers.

What Are KEQU's Competitive Advantages?

• Established brand reputation since 1906.
• Diverse product portfolio catering to multiple sectors.
• Strong distribution network through dealers, subsidiaries, and national distributors.
• Expertise in designing and manufacturing specialized furniture solutions.

What Does KEQU Do?

Founded in 1906, Kewaunee Scientific Corporation has evolved into a leading designer, manufacturer, and installer of laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two primary segments: Domestic and International. Kewaunee's comprehensive product portfolio includes steel, wood, and laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories. These products cater to a diverse range of applications, including chemistry, physics, biology, and general science laboratories. Kewaunee serves the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and healthcare markets. The company also provides technical products for facilities manufacturing computers and light electronics, as well as laminate caseworks for educational, healthcare, and industrial settings. Kewaunee distributes its products through dealers, subsidiaries, and a national distributor, maintaining a strong presence in both domestic and international markets. Headquartered in Statesville, North Carolina, Kewaunee Scientific Corporation continues to innovate and adapt to the evolving needs of its diverse customer base.

What Products and Services Does KEQU Offer?

• Designs and manufactures laboratory furniture.
• Provides healthcare furniture solutions.
• Offers technical furniture for computer and electronics manufacturing facilities.
• Installs furniture and infrastructure products.
• Operates through Domestic and International segments.
• Provides design services related to its products.

How Does KEQU Make Money?

• Manufactures and sells laboratory, healthcare, and technical furniture.
• Generates revenue through product sales and installation services.
• Distributes products through dealers, subsidiaries, and a national distributor.

What Industry Does KEQU Operate In?

Kewaunee Scientific Corporation operates in the furnishings, fixtures, and appliances industry, which is influenced by construction spending, R&D investments, and economic cycles. The laboratory furniture market is expected to grow, driven by advancements in biotechnology and pharmaceutical research. Competition includes both large furniture manufacturers and specialized laboratory equipment providers. Kewaunee differentiates itself through its comprehensive product range and its focus on both domestic and international markets. The company's ability to adapt to changing industry trends and customer needs will be crucial for maintaining its competitive edge.

Who Are KEQU's Key Customers?

• Pharmaceutical companies
• Biotechnology firms
• Educational institutions (universities and schools)
• Healthcare facilities (hospitals and clinics)
• Industrial and chemical companies
• Government and research institutions

Over the past six months, Kewaunee Scientific Corporation insiders filed 45 SEC Form 4 transactions — 31 sales and 14 purchases. On net that is roughly 7K shares acquired (about $2.5M) — insiders putting money in tends to read as conviction.

Kewaunee Scientific Corporation's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.86 places it in the grey zone, a middle ground that warrants monitoring.

Return on equity for Kewaunee Scientific Corporation stands at 13.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.4%, showing how much profit it generates from its asset base. KEQU trades at a trailing price-to-earnings ratio of 12.08, below the Consumer Cyclical sector average of ~32.70x. A current ratio of 2.18 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 9.2%, the inverse of the P/E and a quick read on earnings relative to price.

Kewaunee Scientific Corporation (KEQU) Valuation Context

Valued at $99.1M, KEQU is classified as a micro-cap stock. Relative to its peer group, KEQU's quantitative score of 56/100 is roughly in line with the peer average of 57/100.

KEQU Revenue & Earnings Trend

In Jul 2026, KEQU generated $66.3M in top-line revenue, marking a sequential decrease of 7.1%. The company recorded net income of $1.7M, with diluted EPS of $0.58. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Consumer Cyclical. Across the four most recent quarters, KEQU averaged $0.69 in diluted EPS.

Company Profile

Kewaunee Scientific Corporation operates in the Furnishings, Fixtures & Appliances industry within the Consumer Cyclical sector. It is headquartered in Statesville, US. The company is led by CEO Thomas David Hull. KEQU has traded publicly since 1980.

KEQU Financials

KEQU Latest News

KEQU Analyst Consensus

KEQU MoonshotScore

KEQU Consumer Cyclical Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources